Posted by linkadge on May 9, 2006, at 18:24:15
In reply to Statistical question on SSRIs - L dL Statistics » linkadge, posted by Squiggles on May 9, 2006, at 17:51:23
The way I see the problem with antidepressant drugs that work via dopamine, is not that they lack efficacy, but is that they often posess potential for abuse.
Dopamine agonists used in parkinsons disease have antidepressant properties.
I think that a company is afraid to make a drug that has abuse potential, even if it is a very effective antidepressant, because it could be pulled from the market if people are abusing it.
Linkadge
poster:linkadge
thread:640557
URL: http://www.dr-bob.org/babble/20060504/msgs/641902.html